All News

in Events

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending the 14th Annual World ADC Event in London on 13th and 14th of March 2024. Physiomics’ CEO, Dr Pete Sargent and Head of Business Development, Hayley Close will be attending the event which is Europe’s definitive...

01 Mar

Notice of Results and Investor Presentation

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it will be posting its interim results on Thursday 7 March 2024. The Company will provide a live presentation update in-line with these results via Investor Meet Company on 18 March 2024 at 12:00 pm GMT. During this presentation,...

23 Feb

News update from Physiomics February 2024

in Blog

Leading mathematical modelling company, supporting oncology drug development. From us to you - curated cutting-edge research and insights. Welcome to our newsletter, where we share the latest updates from Physiomics and offer insights on the pivotal news shaping the dynamic world of drug development. Top news Welcoming Peter Sargent as newly appointed CEO Peter, who joined Physiomics in September 2023 as Chief Operating Officer, has now been appointed to...

19 Feb

Contract Award

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has been chosen by The University of Sheffield (the “University”) to support a grant funded project focused on an insect (Fruit fly) model of cancer treatment. The value of this work to Physiomics will be £45k and...

14 Feb

Celebrating International Day of Women and Girls in Science with the brilliant women at Physiomics

in Other News

11th of February was the International Day of Women and Girls in Science. On a day that was created to promote equal representation and gender equality in the science, technology, engineering and mathematics (STEM) disciplines, Physiomics are proud to have a team of scientist that is made up of 50% women. To mark the occasion, we have taken the opportunity to celebrate and get to...

06 Feb

Options Award

Physiomics plc (AIM: PYC), announces an award of share options (the “Options”) over ordinary shares of 0.4p each in the Company (“Ordinary Shares”). The Company considers that it is important to incentivise its key executives to create shareholder value and, as such, today the Board has approved the award of the following options to Dr Peter Sargent under the Company’s existing share option scheme (the...

05 Feb

Contract Award

by Peter Sargent

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has been awarded a further contract by existing client, Numab Therapeutics (“Numab”). The project involves Pharmacokinetic-Pharmacodynamic (PKPD) modelling in support of one of Numab’s oncology assets entering the clinic and will help inform dose and scheduling decisions. Dr...

02 Feb

IMC Presentation on Company Website

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, recently provided a brief update on the Board changes via Investor Meet Company and has updated its website with the presentation. The presentation and Q&A from the meeting are now available at the Company’s website: www.physiomics.co.uk/portfolio-item/investor-presentation-board-changes Enquiries: Physiomics plc Dr Jim Millen, Non-Executive Chairman, +44 (0)1235 841575 Dr...

23 Jan

IMC Presentation on Board Changes